Portfolio manager, Dr Bianca Ogden, drills down on two healthcare stocks, an old favourite, AstraZeneca and a more recent addition, Takeda and explains what makes them a typical Platinum stock. Investing in companies facing temporary challenges and therefore often misunderstood by the market, can deliver results for patient investors.
Disclaimer
DISCLAIMER: The above information is commentary only (i.e. our general thoughts). It is not intended to be, nor should it be construed as, investment advice. To the extent permitted by law, no liability is accepted for any loss or damage as a result of any reliance on this information. Before making any investment decision you need to consider (with your financial adviser) your particular investment needs, objectives and circumstances.